Conmed (CNMD) Revenue Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.38% |
| Dec 31, 2025 | 8.10% |
| Sep 30, 2025 | 7.28% |
| Jun 30, 2025 | 16.76% |
| Mar 31, 2025 | 8.46% |
| Dec 31, 2024 | 5.49% |
| Sep 30, 2024 | 6.28% |
| Jun 30, 2024 | 6.87% |
| Mar 31, 2024 | 7.42% |
| Dec 31, 2023 | 6.17% |
| Sep 30, 2023 | 8.53% |
| Jun 30, 2023 | 8.34% |
| Mar 31, 2023 | 7.90% |
| Dec 31, 2022 | 2.42% |
| Sep 30, 2022 | 7.67% |
| Jun 30, 2022 | 7.05% |
| Mar 31, 2022 | 5.37% |
| Dec 31, 2021 | 6.07% |
| Sep 30, 2021 | 6.13% |
| Jun 30, 2021 | 5.70% |
| Mar 31, 2021 | 5.13% |
| Dec 31, 2020 | 5.77% |
| Sep 30, 2020 | 7.05% |
| Jun 30, 2020 | -2.71% |
| Mar 31, 2020 | 3.76% |
| Dec 31, 2019 | 6.32% |
| Sep 30, 2019 | 5.95% |
| Jun 30, 2019 | 4.84% |
| Mar 31, 2019 | 3.72% |
| Dec 31, 2018 | 3.57% |
| Sep 30, 2018 | 2.45% |
| Jun 30, 2018 | 1.98% |
| Mar 31, 2018 | 1.56% |
| Dec 31, 2017 | 2.03% |
| Sep 30, 2017 | 0.89% |
| Jun 30, 2017 | 0.77% |
| Mar 31, 2017 | -0.81% |
| Dec 31, 2016 | 1.92% |
| Sep 30, 2016 | 1.35% |
| Jun 30, 2016 | 1.09% |
| Mar 31, 2016 | -0.25% |
| Dec 31, 2015 | 0.74% |
| Sep 30, 2015 | -0.35% |
| Jun 30, 2015 | -0.01% |